Therefore, the antibody is decreasing the concentration of free LH that is able to interact with the receptor; the antibody is neutralizing the effect of the hormone (n=2). Interestingly, the curve is relatively similar to the one obtained using calcium measurements in Figure 2D due to the direct link of the calcium concentration on the activity of clytrin. LH was added at time zero, and measurements were obtained from second 5 onwards for 3 minutes. The lag---phase is due to the opening and closing of the box for the addition of the solution to the reservoir. 
SI

Characterization of the HTS233L LHHCG cell line and the antibody
In first experiments, the cells were tested for their luminescence response to LH, and the purchased antibody for its neutralizing ability thereof. Furthermore, the generated cellular dose---response curve served as a standard curve for comparison with vesicle experiments later on. Here, cells were seeded into µslides (ibidi, Germany) and loaded with colenterazine hcp in HBSS as described in the cell line manual.
After the incubation time, luteinizing hormone was added to the cells and the generated luminescence was recorded. Indeed, the cells are responding to the stimulus with the production of bioluminescence with an EC50 value of 10.2 ± 2.4 nM (SI Fig.  1  a) . As expected, the experiment shows a high cellular sensitivity to the presence of LH. Next, the supplied solution was spiked with different concentrations of the purchased anti---LH antibody. As visible in SI Fig. 1 b, the recorded luminescence signal decreased with increasing concentration of antibody, indicating that the antibody is able to reduce the concentration of LH that is able to interact with the receptor, therefore neutralizing the hormones' effect.
Calculations for clinical relevant samples
However, the actual LOD of the nAb present in clinical samples will not only depend on its concentration, but also on its dissociation constant. The commercial antibody used in this study has a fairly high affinity to LH (Kd 1.5 nM). In contrast, the dissociation constant of endogenously produced antibodies can vary from high pM to low µM values, and the concentration in serum during an active immune response may vary from low to high nM concentrations. For example, in a clinical report about neutralizing antibodies against HCG 35 , the clinicians found a low affinity antibody (Kd 714 nM), but the antibody was present in a rather high concentration of 418 nmol/L. Based on the results with our method, we can calculate the limit of detection for antibodies with higher dissociation constants (Fig. 5) .
We calculated the limit of detection of the method for different dissociation constants of the antibody using the following relation: When compared to the example mentioned above, the method would be sufficiently sensitive for the detection of the nAb. This finding makes us confident that the analytical setup is sensitive enough for the analysis of clinical samples, the next step in that has to be done in order to show the usability of the platform.
